Updated on January 26, 2021. On November 2, 2020, Nostrum Laboratories, Inc announced a voluntary recall of 2 lots (MET200101, Exp 5/2022 and MET200301 Exp 5/2022) and expanded with additional lots on January 4, 2021 (MET200501 Exp 7/2022) and January 25, 2021 (MET200601 Exp 7/2022) of Metformin Hydrochloride Extended-Release Tablets, USP 750mg.
Learn more
Marksans Pharma voluntarily recalled a single lot of Metformin Hydrochloride Extended-Release Tablets, USP 500mg (Lot # XP9004), distributed by Time-Cap Labs Inc.
Learn more